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Investigation of downstream processing of nanoﬁbrous amorphous solid dispersions to generate tablet
formulation is in a quite early phase. Development of high speed electrospinning opened up the pos-
sibility to study tableting of electrospun solid dispersions (containing polyvinylpyrrolidone-vinyl acetate
and itraconazole [ITR] in this case). This work was conducted to investigate the inﬂuence of excipients on
dissolution properties and the feasibility of scaled-up rotary press tableting. The dissolution rates from
tablets proved to be mainly composition dependent. Magnesium stearate acted as a nucleation pro-
moting agent (providing an active hydrophobic environment for crystallization of ITR) hindering the total
dissolution of ITR. This crystallization process proved to be temperature dependent as well. However, the
extent of dissolution of more than 95% was realizable when a less hydrophobic lubricant, sodium stearyl
fumarate (soluble in the medium), was applied. Magnesium stearate induced crystallization even if it was
put in the dissolution medium next to proper tablets. After optimization of the composition, scaled-up
tableting on a rotary press was carried out. Appropriate dissolution of ITR from tablets was main-
tained for 3 months at 25C/60% relative humidity. HPLC measurements conﬁrmed that ITR was
chemically stable both in the course of downstream processing and storage.
© 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.Introduction
Formation of amorphous solid dispersion has been frequently
applied over the last 2 decades in order to enhance the bioavail-
ability of poorly water soluble drugs (Biopharmaceutical Classiﬁ-
cation System II and IV class). The processes of spray drying and
melt extrusion have been examined thoroughly and have become
well-described with years.1-3 The most relevant features of solid
dispersions are in fact the enhancement of dissolution and the
question is whether the enhanced dissolution properties can be
maintained in ﬁnal products (i.e., tablets) or not. Dissolution from
tablets is usually slower due to the disintegration step and pro-
longed wetting. Meanwhile, the extent of dissolution usually doesinterest.
: þ36-1463-1424; Fax: +36-
3-1424; Fax: +36-1463-1150).
agy), gmarosi@mail.bme.hu
®. Published by Elsevier Inc. All rignot change signiﬁcantly with tablets4-7 although both increases8-10
and decreases6,7,11 were reported. Faster dissolution rates from
tablets can be attributed either to a step decreasing the particle size
before tableting12 or to the fact that gelling of the polymer is less
probable in tablets if each solid dispersion particle is dispersed
completely allowing rapid wetting.10
Another very important aspect is the maintenance of super-
saturation during dissolution from a tablet, which can be chal-
lenging. Rapid dissolution from amorphous solid dispersions
enables a supersaturated state of the active pharmaceutical ingre-
dient (API), which can generate higher bioavailability, but it might
initiate precipitation.13 Therefore, amorphous solid dispersions
with slower dissolution rates are sometimes more useful as they
can prolong the time of supersaturation at a lower level.14,15 In
order to predict supersaturation and precipitation phenomena
under in vivo circumstances, some in vitro models have been
developed.14,16,17 Tableting can enable adjusting the dissolution rate
through appropriate compression force and composition, thus
maximizing bioavailability.18hts reserved.
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bioavailability depends on the maintenance of supersaturation.
Polymers that are able to form H-bonds with the API can usually
prolong the supersaturated state realizing a higher bioavail-
ability.15 Vandecruys et al.19 screened some formulation excipi-
ents (with 25 drug candidates) that affect supersaturation by
various mechanisms. Surfactants and hydroxypropyl-ß-cyclodex-
trin were found to be the best at augmenting the extent of
supersaturation (enhancing the solubility), while pharmaceutical
polymers (e.g., hydroxypropyl methylcellulose and poly-
vinylpyrrolidone) were more useful at maintaining the stability of
supersaturated state but did not create a high supersaturation
extent. However, disadvantageous changes generated by excipi-
ents (through physical or chemical interactions with the drug)
have been reported too.20 In one case, API, having low dose, was
partly bound to microcrystalline cellulose that led to a dissolution
failure.21 Magnesium stearate (MgSt), which is of particular in-
terest in this work, decreased antibacterial activity of cetylpyr-
idinium chloride by adsorbing it onto the stearate anion.22
The industrial feasibility of electrostatic spinning, which is a
gentle way to produce amorphous solid dispersions and solutions,
is promising. Processes derived from the basic technology are
vividly investigated for versatile pharmaceutical applications: melt
electrospinning,23,24 coaxial electrospinning,25,26 triaxial electro-
spinning,27,28 and so on. However, downstream processing (which
is related to scaling-up of the technology) of nanoﬁbers to generate
tablet formulations has not been studied. Because its pharma-
compatible scaled-up technology, called high speed electro-
spinning, is published,29 detailed investigation of its downstream
processing became the next step. The objective of this article was
manifold. First, it was intended to develop tablet formulation, based
on electrospun ﬁbers, from which the release of itraconazole (ITR)
is fast and complete. Furthermore, a crystallization induced by
MgSt was investigated in detail. It was of great importance to carry
out rotary press tableting with optimized composition (another
lubricant sodium stearyl fumarate (SSF) was applied). This is the
ﬁrst time, to the authors' best knowledge, that scaled-up tableting
of an electrospun material (EM) has been accomplished using a
rotary press. Finally, but not the least, it was investigated if physical
and chemical stability of ITR in tablets could be maintained.
Demonstration of large-scale tableting of physically and chemically
stable electrospun ﬁbrous amorphous solid dispersion, formed
with high throughput method, may open up new formulation
possibilities for pharmaceutical scientists.Materials and Methods
Materials
ITR, MgSt, and SSF were provided by Johnson & Johnson Phar-
maceutical Research and Development (Beerse, Belgium). Aerosil®
200 was purchased from Evonik Industries (Essen, Germany).
Microcrystalline cellulose (MCC, Vivapur® 200) was given by JRS
Pharma (Rosenberg, Germany). Mannitol (Pearlitol® 400DC) was a
kind gift from Roquette Pharma (Lestrem, France). PVPVA64 and
Kollidon® CL were supplied by BASF (Ludwigshafen, Germany).Preparation of EM by High Speed Electrospinning
EMwas prepared according to the description provided by Nagy
et al.29 The high speed electrospinning of the solution with
PVPVA64 (60%) and ITR (40%) in dichloromethane-ethanol (2:1)
was performed under the following conditions: 50 kV voltage,
40,000 rpm spinneret rotational speed,1500mL/h feeding rate, andambient temperature. Further information and basic characteriza-
tion can be found in the aforementioned article.Preparation and Characterization of Tablets
Tablets were compressed on a Huxley Bertram hydraulic
compaction simulator equipped with 9.5-mm ﬂat-face punches
and instrumented die. The compression proﬁles were created with
the compaction simulator software for a Courtoy Modul S press (B-
tooling). Hardness was measured on an ERWEKA TBH30 hardness
tester with 3 tablets. Tensile strength was calculated from hardness
as follows:
T ¼ 2$H
p$t$d
where T is the tensile strength, H is hardness, t is thickness of
tablets, and d is the width of the tablet. Friability was measured on
ERWEKA TAR20 friability tester after 4 min at 25 rpm on 10 tablets.
Porosity was calculated as follows:
P ¼ 1
m
100$p$

d
2
2
$t
r
where P is the porosity,m is the mass of the tablet, d is the diameter
of the punch, t is the thickness of the tablet, and r is the true density
of the blend. True densities of the blends were determined on an
Accupyc 1330 helium pycnometer (Micromeritics, Atlanta, GA).
Disintegration time was determined on an ERWEKA ZT71 disinte-
gration tester in tap water at 37C with 3 tablets.
Disintegration time and tensile strength data were evaluated
with Statistica 12 software (Tulsa, OK). Optimization was carried
out with the same software (desirability function). It optimizes the
dependent variables so the disintegration time is minimal and
tensile strength is maximal. The software analyzes the whole
studied area and chooses the point which is the best for both
dependent variables (with same importance).Dissolution Test and Flask Measurements
Dissolution tests were executed under non-sink conditions with
3 parallel measurements on a DISTEK 2100B dissolution tester.
Measurement parameters were as follows: 900 mL of 0.1 N HCl,
United States Pharmacopeia Dissolution Apparatus 2, 100 rpm
paddle speed, variable temperature (37 ± 0.5C or room tempera-
ture 22C). Manual sampling was applied and the absorption of the
samples was measured on an Agilent ultraviolet (UV) spectropho-
tometer (Agilent, Santa Clara, CA) at 254 nm. Each tablet contained
50 mg of ITR. A calibration was prepared for the determination of
ITR concentration. For the stock solution, the crystalline ITR was
dissolved in ethanol and then ﬁlled up with pH1 acid. The ratio of
the 2 solvents was as follows: ethanol:pH1 1:9. Ethanol did not
cause any shift or alteration in the UV spectrum of ITR. The cali-
bration range was 1-50 mg/L.
Flask measurements were carried out in lockable ﬂasks with a
volume of 900 mL at 4 different temperatures (22C, 32C, 37C,
and 45C). The neat EM, blend, or tablet equal to 50 mg ITR
along with stir bars was put into the ﬂask (ﬁlled with 900 mL
of 0.1 N HCl) located on a magnetic stirrer. After half an hour of
stirring (500 rpm), absorption was measured on an Agilent UV
spectrophotometer at 254 nm. If it was necessary, temperature was
set for the solution prior to addition of tablets.
Table 1
Composition of Tablets
Variable Material Blend 1
(F1-F3)
Centre Blend
(F4-F6)
Blend 2
(F7-F9)
Composition EM (mg) 125 (25%) 125 (22.4%) 125 (19.5%)
MCC (mg) 157 (31.5%) 183 (32.8%) 219 (34.2%)
Mannitol (mg) 157 (31.5%) 183 (32.8%) 219 (34.2%)
Kollidon CL (mg) 50 (10%) 56 (10%) 65 (10%)
Aerosil 200 (mg) 5 (1%) 5.6 (1%) 6.5 (1%)
Magnesium stearate
(mg)
5 (1%) 5.6 (1%) 6.5 (1%)
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After dissolution tests the ﬁltered solid residues were investi-
gated with Raman spectrometry to determine the quality of
undissolved or precipitated materials. The point measurements
were performed using Horiba Jobin-Yvon LabRAM-type micro-
spectrometer with external 785 nm diode laser source and
Olympus BX-40 optical microscope. The laser beamwas focused by
an objective of 50 to the ﬁne particles to acquire Raman spectrum.
The confocal hole of 1000 mm and 950 groove/mm grating mono-
chromator were used in confocal system and for light dispersion.
The spectral range of 460-1680 cm1 was detected as the relevant
range with 3 cm1 resolution. Each spectrum was collected at 30 s
and 3 spectra were averaged per point.Polarized Light Microscopy
The samples ﬁltered after dissolution test were investigated by
Amplival, Carl Zeiss Jena polarized light microscope (Jena, Germany).Scaled-Up Tableting on a Rotary Press
Scaled-up tableting was carried out on a Kambert KMP-8 table
top rotary press (Ahmedabad, India) equipped with eight 8  16
mm oblong punches. In total, 9 and 23 rpm were applied as tab-
leting speed. The optimized formulation (76.25% ﬁllers fraction)
with 1.5% SSF as lubricant was used for scaled-up tableting.Storage
Tablets were kept in a Binder KBF 720 climate chamber at 25C/
60% relative humidity (RH) in open holders.Table 2
Factors of the Performed Experimental Design and the Obtained Results (n ¼ 3)
Batch
Number
Compression
Force (kN)
Fillers
Fraction (%)a
Tensile
Strength
(N/mm2)
Disintegration
Time (s)
F1 3.0 71.4 0.67 ± 0.08 98 ± 9
F2 4.5 71.4 1.37 ± 0.10 289 ± 80
F3 6.0 71.4 2.23 ± 0.03 832 ± 56
F4 3.0 74.6 0.60 ± 0.01 38 ± 4
F5 4.5 74.6 1.20 ± 0.05 226 ± 24
F6 6.0 74.6 1.96 ± 0.12 343 ± 105
F7 3.0 77.8 0.52 ± 0.02 25 ± 4
F8 4.5 77.8 1.03 ± 0.03 93 ± 12
F9 6.0 77.8 1.84 ± 0.09 363 ± 15
OT 6.0 76.25 1.94 ± 0.04 337 ± 36
að mfillersmfillersþmEMÞ  100.
OT, optimized tablets.HPLC Studies
Maintenance of chemical stability of ITR in the tablets during
storage period was determined by analyzing the decomposition
byproducts using RP-HPLC (Agilent 1200 series LC System). The
HPLC method of Ph. Eur. 5.0 for ITR was adopted. Accordingly, a
gradient elution of 27.2 g/L tetrabutylammonium hydrogen sulfate
and acetonitrile was performed at a ﬂow rate of 1.5 mL/min and
25C started at 20% acetonitrile, increased linearly to 50% over 20
min and maintained for 5 min, then returned to the initial
composition over 5 min. The UV detection wavelength was set to
225 nm. The samples were dissolved in a mixture of equal volumes
of methanol and tetrahydrofuran obtaining a 1 mg/mL solution of
ITR, and 10 mL of this stock solution was injected onto the column
(Agilent Zorbax Eclipse C18 column [3.5 mm; 100  4.6 mm]). The
amount of degradation products was determined based on the peak
areas. The chromatography tests were done in duplicate.Results and Discussion
An experimental design with independent variables of
compression force and composition of tablets was carried out in
order to optimize the disintegration time and tensile strength.
Composition of tablets varied in the ratio of EM to ﬁllers (Table 1),
while compression force was set to 3, 4.5, and 6 kN for each
composition.
The design of experiments and obtained results are presented in
Table 2. Optimal point was found to be at 76.25% ﬁllers fraction and
6 kN compression force (both independent variables had the same
importance).The Dissolution Tests
Dissolution tests were carried out with certain batches of the
experimental design in order to assess the in vitro drug dissolution
(Fig. 1). All curves depict the mean of 3 parallel measurements, and
deviation is not displayed to avoid clutter (but deviations stayed
under 5%).
Dissolution rates in the ﬁrst 10minwere quite similar for F7 and
F9 tablets (containing the same blend). Interestingly, dissolution of
F9 tablets was signiﬁcantly faster than that of F1 tablets althoughFigure 1. Dissolution proﬁles of tablets containing ITR-PVPVA64 electrospun solid
dispersion and 1% MgSt (n ¼ 3). Parameters: USPII, 900 mL of 0.1 N HCl, 100 rpm, 37 ±
0.5C, 50 mg dose.
Figure 2. Polarized light microscopy image of ﬁltered sample after dissolution of tablet with (a) MgSt and (b) Raman spectra of (1) MgSt, (2) crystalline ITR, and (3) crystal in the
ﬁltered powder.
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that direct correlation between disintegration time and dissolution
was reported by several authors.30,31 Consequently, this suggests
that dissolution rate is dependent on composition rather than on
disintegration time and it is determined by particle size after
disintegration. One possible explanation is that dissolution was
facilitated in case of F9 by better and faster wetting. Wetting was
promoted by 2 factors: more mannitol in the tablet and more MCC
generating a signiﬁcant distance among EM particles (even during
dissolution). On the other hand, these MCC aggregates are not
disintegrating quickly due to the high compression force applied
(MCC particles deform plastically and induce a strong adhesion).
However, such visible divergence cannot be observed among F5, F1,
and optimal tablets, which had similar dissolution curves in spite of
differences in composition and disintegration time. F3 tablets (with
low ﬁllers fraction and high compression force) had deﬁnitely the
lowest dissolution rate and extent.
The Crystallization Phenomenon
Amorphous solid dispersion prepared by high speed electro-
spinning was reported to release ITR of more than 95% during 20
min and 100% after 60 min.29 For tablets, dissolution is obviously
slower due to the disintegration step before wetting. It was not
obvious, however, why the tablets released only ~80% of ITR.Figure 3. Temperature and lubricant content dependency of ITR dissolution proﬁle
(n ¼ 3). Parameters: USPII, 900 mL of 0.1 N HCl, 100 rpm, 37 ± 0.5C, 50 mg dose.Dissolution extent seems to be somewhat correlated with disso-
lution rate because F7 tablets exhibited the highest, while F3 the
lowest dissolution rate.
Flask measurements were carried out in order to check whether
tablets contained the appropriate amount of ITR. The results
conﬁrmed that blends and tablets contained 99.85 ± 1.03% and
98.86 ± 1.81% of 50mg ITR, respectively; therefore no loss of EM has
occurred during blending or tableting.
There was a difference between dissolution tests and ﬂask
measurements. The previous ones were executed at elevated
temperature (37C), while the ﬂask measurements were executed
at room temperature (~22C). Thus, the temperature dependency of
the amount of dissolved ITR was investigated at 4 different tem-
peratures. Interestingly, lower amount of dissolved ITR was
observed when the temperature was increased: 101.3 ± 1.52%, 96.4
± 0.94%, 91.0 ± 1.25%, and 76.5 ± 2.43% at 22C, 32C, 37C, and
45C, respectively. In these cases, wetting was of course signiﬁ-
cantly better than during dissolution tests. At higher temperature
solubility is supposed to be higher as well. However, these results
suggest obvious negative correlation between temperature and
extent of dissolved drug, which can indicate that ITR crystallizes
during the dissolution tests.
To conﬁrm this concept, a dissolution test was performed at
37Cwith a tablet that contained only EM, mannitol, andMgSt, that
is, without MCC and crospovidone, the water insoluble crystals
which would disturb detection (consequently, no complete disso-
lution was achieved due to the prolonged disintegration). This
experiment was carried out in order to detect crystalline ITR which
could be formed during dissolution. The solid material in the vessel
was ﬁltered after the test in a glass ﬁlter funnel and analyzed by
polarized light microscopy (Fig. 2a). PVPVA64 and mannitol dis-
solved in the dissolution medium (37C) and were separated by
ﬁltration. Images clearly showed the presence of crystalline mate-
rial. According to the Raman investigations, the material was mixedTable 3
Dissolution Extent (at 37C), Tensile Strength, Disintegration Time, and Porosity
Comparison of Tablets With Different Lubrication (n ¼ 3)
Tablet Dissolution
Extent (%)
Tensile Strength
(N/mm2)
Disintegration
Time (s)
Porosity
1% MgSt 80.2 ± 1.4 1.94 ± 0.04 337 ± 36 0.213 ± 0.005
0.5% MgSt 85.2 ± 1.9 2.03 ± 0.04 280 ± 20 0.199 ± 0.004
3% SSF 98.5 ± 2.2 1.61 ± 0.11 438 ± 25 0.204 ± 0.002
1.5% SSF 97.0 ± 2.2 2.16 ± 0.18 443 ± 29 0.210 ± 0.002
Parameters of the dissolution test: USPII, 900 mL of 0.1 N HCl, 100 rpm, 37 ± 0.5C,
50 mg dose.
Figure 4. Polarized light microscopy image of ﬁltered sample after dissolution of tablet with (a) SSF and (b) Raman spectra of (1) SSF, (2) crystalline ITR, and (3) ﬁltered powder.
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one crystal by changing the objective to a 100magniﬁcation (spot
size ~0.8 mm) crystalline ITR was detected (Fig. 2). If the ratio of
peaks at 666 and 639 cm1 of ITR is over 1.05, it means that the
examined sample is crystalline.32 It is clearly visible in the ﬁgure
that 666 cm1 peak has larger intensity than the peak at 639 cm1.
The extent of crystallization was not dependent clearly on
dissolution rate (and disintegration time) with the tablets from the
DoE (Fig.1) although some correlation can be noticed. An excipient-
induced crystallization seemed more likely in this case. MgSt was
suspected to induce crystallization as a hydrophobic material. Thus,
the goal of our further experiments was to reveal the possible
adverse effects.
In subsequent dissolution tests, the following parameters were
changed: amount of MgSt (0.25%, 0.5%, and 1%) and temperature of
the test (37C and room temperature 22C) (Fig. 3).
Tablets with 0.25% MgSt exhibited the fastest dissolution, which
can be attributed to rapid wetting in the ﬁrst 10 min. The
compression properties deteriorated, however, at such a low
lubricant content. More theMgSt is included in the tablet, the lower
dissolution extent is realizable. The effect of the presence of MgSt
became clear when dissolutions with SSF containing tablets were
carried out (see Tablets With SSF).
The highest extent of dissolved ITR could be achieved when
dissolution was performed at 22C because ITR seemed not to
crystallize in this case. This phenomenon can be attributed to 2
temperature-dependent competitive processes: dissolution and
crystallization of ITR. Molecular mobility obviously becomes higher
with increasing temperature. According to ﬂask measurements, the
amount of dissolved ITR is decreasing with rising temperature.
Furthermore, an exponential correlation can be observed between
the crystallized amount and temperature. Therefore, the kinetics of
this crystallization phenomenon might follow the Arrhenius
equation. As the temperature is increasing the activation energy of
crystallization can be overcome progressively and crystallization
becomes more and more prevalent, probably on the hydrophobic
surface of MgSt.Figure 5. Dissolution from optimal tablets (with SSF) and with additional MgSt
powder in the dissolution medium (n ¼ 3). Parameters: USPII, 900 mL of 0.1 N HCl, 100
rpm, 37 ± 0.5C, 50 mg dose.Tablets With SSF
In order to achieve higher extent of dissolution (while main-
taining good compression properties), MgSt was changed to a less
hydrophobic lubricant, SSF. To explore the effect of the new lubri-
cant, concentration of 3% and 1.5% was used as a ﬁrst and second
trial. Dissolution extent, tensile strength, disintegration time, and
porosity were checked. As a comparison to tablets with 3% and 1.5%SSF, features of tablets with 1% and 0.5% MgSt are also described
(Table 3).
For SSF containing tablets, >95% dissolution could be achieved
which is, from pharmaceutical point of view, satisfactory. Rate and
extent of dissolution and compression properties were acceptable
(data not shown) with both 1.5% and 3% SSF leading to the
conclusion that both are applicable in a formulation.
Generally, increasing the porosity of a tablet decreases its me-
chanical strength and this relationship is sometimes linear.33 Tab-
lets containing MgSt behaved accordingly. The bonding capacity of
particles decreases (and porosity increases) at higher (i.e., 1%) MgSt
concentration due to higher coverage of their surface with hydro-
phobic layer. Tablets with less MgSt (and thus less hydrophobic
coverage) disintegrated within a shorter time as water can come
into contact with particles faster and more easily. In case of more
hydrophilic SSF porosity decreased with increasing lubricant con-
tent but the introduction of 3% lubricant yet reduced the tensile
strength because of the plasticizing effect of the low molecular
weight additive. The water soluble SSF does not affect the wetting
and disintegration time signiﬁcantly. Friability was found to be
0.05% with tablets containing 1.5% SSF. Based on the results blend
with 1.5% was chosen for further experiments.
As a reference it was checkedwhether crystallization takes place
during dissolution from tablets containing EM, mannitol, and SSF.
Figure 6. Dissolution of ITR from randomly chosen tablets produced on rotary press (a) and from tablets at starting point and kept at 25C/60% RH for 1 and 3 months (b). Pa-
rameters: USPII, 900 mL of 0.1 N HCl, 100 rpm, 37 ± 0.5C, 50 mg dose.
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crystals (Fig. 4).
Polarized light microscopy and Raman spectrometry conﬁrmed
that the pure ITR in the ﬁltered material is (measurements of
random points of the sample) amorphous: the intensity of peak at
666 cm1 is smaller than that of 639 cm1, unlike in the spectrum of
crystalline ITR (Fig. 4) and sample from MgSt dissolution (Fig. 2).
Although 100% dissolution was not achieved due to long disinte-
gration, ITR did not crystallize with SSF in an extent that would be
perceivable with microscopy and Raman spectroscopy. On the
other hand, ITR in its highly supersaturated state can adsorb onto
the surface of MgSt and crystallize there. To conﬁrm this assump-
tion MgSt (equal to 1%) has been added to the dissolution medium
of tablets of good dissolution in order to ﬁnd out whether MgSt
induces crystallization. MgSt was put into a basket moving in the
vessel. Some of it was ﬂoating in course of the test, thus probably
less of it was available as a crystallization substrate. The results are
shown in Figure 5.
Clearly, MgSt generated crystallization of API although this ef-
fect was less extensive than in the cases of MgSt containing for-
mulations. Based on these experiments, MgSt seems to act as
nucleation promoting agent for amorphous ITR providing a hy-
drophobic environment and compromises its advantageous disso-
lution characteristics. Both the presence of MgSt and elevated
temperature (37C) are required for the crystallization process to
occur. The results suggest crystallization of a certain fraction of ITR
even at lower doses if the circumstances discussed above are given.Scaled-Up Tableting on a Rotary Press and Stability Investigation of
Tablets
A further investigation of the segregation and feasibility of
scaled-up tableting was performed on a rotary press by varying the
speed of rotation. At the higher speed (23 rpm) a tensile strength of
2.17 ± 0.22 N/mm2 was measured and friability could be kept at
0.02%. Furthermore, relative standard deviation of the mass of
tablet (20 tablets) even decreased slightly (2.23 to 1.91) with
increasing tableting speed.
Advantageous dissolution properties were maintained for the
prepared oblong tablets (Fig. 6). All the 6 randomly chosen tablets
from rotary press tableting batch released more than 95% of ITR
within 2 h (96.1 ± 1.5%) and there was no signiﬁcant difference in
dissolution rates. Furthermore, the tablets kept at 25C/60% RH for
3 months showed very similar dissolution proﬁles like those after
production. Presumably, phase separation and recrystallization didnot happen during the 3-month storage because no change became
apparent in dissolution rates and extents.
To investigate the chemical stability of ITR in tablets, HPLC
measurements were carried out on samples kept maintained at
25C/60% RH for 3 months. In crystalline ITR, 0.32 ± 0.04% impurity
was observed, which did not increase during downstream pro-
cessing (mixing with excipients, compression) and storage under
controlled conditions: the contamination remained at 0.33 ± 0.05%.
Conclusions
Dissolution characteristics of tablets containing high speed
electrospun solid dispersion of ITR and PVPVA64 were investigated
in this work. It was found that MgSt lubricant induced crystalliza-
tion of the drug in course of in vitro dissolution. MgSt compromised
the dissolution characteristics of ITR and this is expected to occur
with some other amorphous APIs. No “spring and parachute” effect
was observed; this crystallization process likely starts at the
beginning of dissolution and expands to a level determined by API,
amount of MgSt, and temperature. Conversely, SSF dissolves in the
medium and does not render a possibility for crystallization.
Therefore, higher amount of ITR could be dissolved.
The feasibility of scaled-up tableting of EMs was demonstrated.
Several important scientiﬁc and industrial aspects were assessed
on these tablets and found to be excellent. The potential for scaled-
up tableting of electrospunmaterials (along with good physical and
chemical stability) renders new possibilities for formulation sci-
entists to address challenges related to poorly water soluble drugs.
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